They also wanted to know if treatment with VEGF-containing NPs continued to improve cardiac function and was designed to protect against left ventricular remodeling in the hearts of mice that had been given an experimentally stimulated myocardial infarction. This evidence concerns the gene VEGFA and myocardial infarction.